We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current XNCR market cap is 1.14B. The company's latest EPS is USD -2.0629 and P/E is -9.00.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 27.3M | 21.61M | 18.96M | 45.52M | 59.16M |
| Operating Income | -38.21M | -42.73M | -59.37M | -26M | -18.27M |
| Net Income | -32.76M | -12.04M | -60.76M | -21.95M | -24.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 156.7M | 122.69M | 275.11M | 164.58M | 168.34M |
| Operating Income | 13.82M | -76.8M | 43.77M | -82.47M | -138.64M |
| Net Income | 26.88M | -69.33M | 82.63M | -55.18M | -126.09M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 835.27M | 846.27M | 803.41M | 778.12M | 778.43M |
| Total Liabilities | 112.57M | 118.77M | 119.83M | 99.25M | 109.42M |
| Total Equity | 722.7M | 727.5M | 683.58M | 678.88M | 669.01M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 670.25M | 703.24M | 838.21M | 846.27M | 952.69M |
| Total Liabilities | 77.05M | 130.8M | 104.71M | 118.77M | 283.56M |
| Total Equity | 593.2M | 572.44M | 733.5M | 727.5M | 669.13M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 48.92M | 24.49M | -30.61M | -68.81M | -96.1M |
| Investing | -144.27M | -119.73M | 48.14M | 46.74M | 92.07M |
| Financing | 4.53M | 5.7M | 922k | 2.84M | 3.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 64.37M | -5M | -16.85M | 24.49M | 85.11M |
| Investing | -50.97M | 100.19M | -46.25M | -119.73M | -111.07M |
| Financing | 10.66M | 18.04M | 43.04M | 5.7M | 26.18M |
| Market Cap | 1.14B |
| Price to Earnings Ratio | -9.00 |
| Price to Sales Ratio | 6.74 |
| Price to Cash Ratio | 21.1 |
| Price to Book Ratio | 1.7 |
| Dividend Yield | - |
| Shares Outstanding | 61.12M |
| Average Volume (1 week) | 488.65k |
| Average Volume (1 Month) | 499.27k |
| 52 Week Change | -34.25% |
| 52 Week High | 28.96 |
| 52 Week Low | 16.49 |
| Spread (Intraday) | 0.05 (0.27%) |
| Company Name | Xencor Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.xencor.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
